Monday, 20 June 2016

Endocrine Testing 2016 World Market Leaders,Future Demand,Company Profiles and Industrial Overview Research Report Forecasting to 2022

WiseGuyReports.com adds“Endocrine Testing 2016 World Market Leaders,Future Demand,Company Profiles and Industrial Overview Research Report Forecasting to 2022”reports to its database.


The endocrine system comprises of the endocrine glands such as the pituitary, thyroid, pancreas, adrenal, etc. These glands secrete hormones that regulate the body’s metabolism, growth, sexual development and function. Endocrine tests help in assessing the normal functioning of the endocrine gland by checking the hormone levels. The tests detect the imbalance in hormonal levels. The various tests, their advantages and uses are described in the report. The endocrine testing market is driven by the increasing incidences of endocrine disorders such as diabetes, thyroid disorders, infertility, etc. This has also resulted in the development of new technologies, which is driving the growth of this market. High development costs required for developing new technologies could impede growth of this market. The opportunities for this market are tremendous as rising incidences of endocrine disorders and increasing health care awareness would require rapid, sensitive and low priced tests.

Endocrine Testing Market by Test

The endocrine tests are used to test the levels of Follicle stimulating hormone(FSH), Human Chorionic Gonadotropin (hCG), Thyroid Stimulating Hormone(TSH), Dehydroepiandrosterone sulfate (DHEAS), Prolactin, Progesterone, Insulin, Cortisol, Testosterone, Estradiol(E2), Luteinizing Hormone (LH) and others. The incidence of diabetes is increasing worldwide. This would require testing of insulin levels. Also, the cases of thyroid disorders are increasing which would further increase the demand for the tests.

For more information or any query mail at sales@wiseguyreports.com  
   
Endocrine Testing Market by Diagnostic Technology

The endocrine tests are Immunoassay, Clinical Chemistry tests, tests utilizing Monoclonal and Polyclonal Antibody, and Tandem Mass Spectroscopy. Mass spectroscopy analysis is the most recent technology available. The sensitivity of the tests using mass spectroscopy is very high.

Endocrine Testing Market by end user

The endocrine tests are used in Hospitals, Physicians Offices, Health Care centers, Commercial Laboratories, etc. Hospitals are the major users for these tests with a large number of people visiting hospitals for testing.

Endocrine Testing Market by Geography

The endocrine testing market is segmented into North America, Europe, Asia Pacific and RoW. The market is dominated by North America followed by Europe, as there is greater awareness in these regions. However, the market in Asia-Pacific is expected to grow as the incidences of endocrine disorders are rising in these regions.

Competitive Analysis

The key players in this market are Quest Diagnostics, Thermo Fisher Scientific, Siemens Healthcare, Ortho Clinical Diagnostics, bioMerieux, Agilent Technologies, Abbott Laboratories and others. In May 2012, Quest Diagnostics announced four new tests panels for congenital adrenal hyperplasis (CAH), an endocrine disorder. The tests promise to provide faster and high quality diagnosis of CAH.

High Level Analysis

According to Porter’s five force model, the bargaining power of the buyer is high in this market, as there are a wide range of test kits manufactured by many companies. The threat posed by new entrants is also analyzed. The key drivers, restraints and opportunities are described to help in better understanding the market. Business strategies implemented by competitors are analyzed. The value chain analysis of the endocrine testing market is strategically dealt with in the report.

Key Benefits

Market segmentation by technology helps in understanding the current technologies as well as future developments on this front
In- depth analysis of tests used would help in identification of future applications
Market estimates for the period of 2012-2020 are given, which would give a clear idea of current and future prospects for the market
Key factors influencing the market are given which would enable a better understanding of the growth of this market
Geographic segmentation would help in identifying untapped regions where expansion could be possible


Key Deliverables

The endocrine testing market is segmented by test, diagnostic technology, end user and geography.

Market by Test

Follicle stimulating hormone(FSH)
Human Chorionic Gonadotropin (hCG)
Thyroid Stimulating Hormone(TSH)
Dehydroepiandrosterone sulfate (DHEAS)
Prolactin
Progesterone
Insulin
Cortisol
Testosterone
Estradiol(E2)
Luteinizing Hormone (LH)

Market by Diagnostic Technology

Immunoassay
Clinical Chemistry
Monoclonal and Polyclonal Antibody
Tandem Mass Spectroscopy

Market by End User

Hospitals
Physicians Offices
Health Care Centers
Commercial Laboratories

Market by Geography
North America
Europe
Asia Pacific
RoW

RESEARCH METHODOLOGY

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

CONTINUE…….


For more information or any query mail at sales@wiseguyreports.com

Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

No comments:

Post a Comment